Imipenem resistance in aerobic Gram-negative bacteria

Journal of Chemotherapy

Volumn 10, Issue 2, 1998, Pages 97-101

  Modakkas, E M ^a   Sanyal, S C ^a,b  

^a IBN SINA HOSPITAL   (Kuwait)

^b Department of Laboratory Medicine ^*  (Kuwait)

Author keywords

Aerobic Gram negative bacteria; Antibiotic resistance; Burn wounds; Imipenem resistance

Indexed keywords

IMIPENEM;

ACINETOBACTER CALCOACETICUS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; BURN; ENTEROBACTER CLOACAE; GRAM NEGATIVE BACTERIUM; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

EID: 0031916991     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1998.10.2.97     Document Type: Article

References (16)

1. Norrby SR. Carbapenems. Med Clin N Am 1995; 79: 745-59.
2. Spencer RC, Bauernfeind A, Garcia-Rodriguez J, et al. Surveillance of the current resistance of nosocomial pathogens to antibacterials. Clin Microbiol Infect 1997; 3 (suppl 1): S21-S35.
3. Tankovic J, Legrand P, De Gatines G, Chemineau V, Brun-Buissou C, Duval J. Characterization of a hospital outbreak of imipenem resistant Acinetobacter baumannii by phenotypic and genotypic methods. J Clin Microbiol 1994; 32:2677-81.
4. Spencer RC. The emergence of epidemic, multiple antibiotic resistant Stenotrophomonas (Xanthomonas) maltophila and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995; 30 (suppl): 453-64.
5. Sanders WE, Sanders CC. Cycling of antibiotics: an approach to circumvent resistance in specialized units of the hospital. Clin Microbiol Infect 1996; 1: 223-225.
6. Livingstone D, Gill MJ, Wise R. Mechanisms of resistance to the carbapenems. J Antimicrob Chemother 1995; 35: 1-5.
7. Mokaddas E, Gang RK, Sanyal SC. Emergence of imipenem resistant Pseudomonas aeuruginosa in a burns unit in Kuwait. J Kuwait Med Assoc 1997; 29: 218-220.
8. Margaret BS, Drusano GL, Standiford HC. Emergence of resistance to carbapenem antibiotics in Pseudomonas aeruginosa. J Antimicrob Chemother 1989; (Suppl.A): 161-167.
9. Trias J, Nikaido H. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1990, 34: 52-7.
10. Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991; 35: 147-51.
11. Pederson SS, Pressler T, Hoiby N, Benton MW, Cock C. Imipenem/cilastatin treatment of multiresistant Pseudomonas aeuroginosa lung infections in cystic fibrosis. J Antimicrob Chemother 1985; 16: 629-35.
12. Quinn JP, Dudeck EJ, Di Vincenzo CA, Lucks DA, Lerner SA. Emergence of resistance to imipenem therapy during therapy for Pseudomonas aeruginosa infection. J Infect Dis 1986; 154: 289-94.
13. Nass T, Nordmann P. Analysis of a carbapenem hydrolysing class A beta-lactamase from Enterobacter cloacae and of its Lys R-type regulatory protein. Proc Natl Acad Sci USA 1994; 91: 7693-97.
14. Scaife W, Young H-K, Paton RH, Amyes SGB. Transferable imipenem resistance in Acinetobacter species from a clinical source. J Antimicrob Chemother 1995; 36: 585-86.
15. Verbest L. Incidence of multiresistance in gram-negative bacterial isolates from intensive care units in Belgium: A surveillance study. Scand J Infect Dis 1991; Suppl 78: 45-53.
16. Amyes SGB, Gemmell CG. Antibiotic resistance. J Med Microbiol 1997; 46: 436-70.